BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

364 related articles for article (PubMed ID: 32117281)

  • 1. Various Tastes of Sugar: The Potential of Glycosylation in Targeting and Modulating Human Immunity via C-Type Lectin Receptors.
    Busold S; Nagy NA; Tas SW; van Ree R; de Jong EC; Geijtenbeek TBH
    Front Immunol; 2020; 11():134. PubMed ID: 32117281
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glycan-Based Cell Targeting To Modulate Immune Responses.
    Johannssen T; Lepenies B
    Trends Biotechnol; 2017 Apr; 35(4):334-346. PubMed ID: 28277249
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Using the glycan toolbox for pathogenic interventions and glycan immunotherapy.
    Li RE; van Vliet SJ; van Kooyk Y
    Curr Opin Biotechnol; 2018 Jun; 51():24-31. PubMed ID: 29175707
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dendritic cells and C-type lectin receptors: coupling innate to adaptive immune responses.
    van Vliet SJ; García-Vallejo JJ; van Kooyk Y
    Immunol Cell Biol; 2008 Oct; 86(7):580-7. PubMed ID: 18679407
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glycan-based DC-SIGN targeting vaccines to enhance antigen cross-presentation.
    van Kooyk Y; Unger WW; Fehres CM; Kalay H; García-Vallejo JJ
    Mol Immunol; 2013 Sep; 55(2):143-5. PubMed ID: 23158834
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cross-presentation through langerin and DC-SIGN targeting requires different formulations of glycan-modified antigens.
    Fehres CM; Kalay H; Bruijns SC; Musaafir SA; Ambrosini M; van Bloois L; van Vliet SJ; Storm G; Garcia-Vallejo JJ; van Kooyk Y
    J Control Release; 2015 Apr; 203():67-76. PubMed ID: 25656175
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glycans from avian influenza virus are recognized by chicken dendritic cells and are targets for the humoral immune response in chicken.
    de Geus ED; Tefsen B; van Haarlem DA; van Eden W; van Die I; Vervelde L
    Mol Immunol; 2013 Dec; 56(4):452-62. PubMed ID: 23911401
    [TBL] [Abstract][Full Text] [Related]  

  • 8. C-Type Lectin Receptor Mediated Modulation of T2 Immune Responses to Allergens.
    Angelina A; Martín-Cruz L; de la Rocha-Muñoz A; Lavín-Plaza B; Palomares O
    Curr Allergy Asthma Rep; 2023 Mar; 23(3):141-151. PubMed ID: 36720753
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plant lectins and their usage in preparing targeted nanovaccines for cancer immunotherapy.
    Gupta B; Sadaria D; Warrier VU; Kirtonia A; Kant R; Awasthi A; Baligar P; Pal JK; Yuba E; Sethi G; Garg M; Gupta RK
    Semin Cancer Biol; 2022 May; 80():87-106. PubMed ID: 32068087
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activation of the C-Type Lectin MGL by Terminal GalNAc Ligands Reduces the Glycolytic Activity of Human Dendritic Cells.
    Zaal A; Li RJE; Lübbers J; Bruijns SCM; Kalay H; van Kooyk Y; van Vliet SJ
    Front Immunol; 2020; 11():305. PubMed ID: 32161592
    [TBL] [Abstract][Full Text] [Related]  

  • 11. C-type lectins on dendritic cells: key modulators for the induction of immune responses.
    van Kooyk Y
    Biochem Soc Trans; 2008 Dec; 36(Pt 6):1478-81. PubMed ID: 19021579
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting C-type lectin receptors with multivalent carbohydrate ligands.
    Lepenies B; Lee J; Sonkaria S
    Adv Drug Deliv Rev; 2013 Aug; 65(9):1271-81. PubMed ID: 23727341
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Melanoma tumour-derived glycans hijack dendritic cell subsets through C-type lectin receptor binding.
    Niveau C; Sosa Cuevas E; Roubinet B; Pezet M; Thépaut M; Mouret S; Charles J; Fieschi F; Landemarre L; Chaperot L; Saas P; Aspord C
    Immunology; 2024 Feb; 171(2):286-311. PubMed ID: 37991344
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Myeloid C-Type Lectin Receptors in Viral Recognition and Antiviral Immunity.
    Monteiro JT; Lepenies B
    Viruses; 2017 Mar; 9(3):. PubMed ID: 28327518
    [TBL] [Abstract][Full Text] [Related]  

  • 15. C-Type Lectin Receptors in Host Defense Against Bacterial Pathogens.
    Mnich ME; van Dalen R; van Sorge NM
    Front Cell Infect Microbiol; 2020; 10():309. PubMed ID: 32733813
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Worms to the rescue: can worm glycans protect from autoimmune diseases?
    Kuijk LM; van Die I
    IUBMB Life; 2010 Apr; 62(4):303-12. PubMed ID: 20101628
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recognition of tumor glycans by antigen-presenting cells.
    Aarnoudse CA; Garcia Vallejo JJ; Saeland E; van Kooyk Y
    Curr Opin Immunol; 2006 Feb; 18(1):105-11. PubMed ID: 16303292
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bacterial glycans and their interactions with lectins in the innate immune system.
    Prado Acosta M; Lepenies B
    Biochem Soc Trans; 2019 Dec; 47(6):1569-1579. PubMed ID: 31724699
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Specific glycan elements determine differential binding of individual egg glycoproteins of the human parasite Schistosoma mansoni by host C-type lectin receptors.
    Meevissen MH; Driessen NN; Smits HH; Versteegh R; van Vliet SJ; van Kooyk Y; Schramm G; Deelder AM; Haas H; Yazdanbakhsh M; Hokke CH
    Int J Parasitol; 2012; 42(3):269-77. PubMed ID: 22673410
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endogenous ligands for C-type lectin receptors: the true regulators of immune homeostasis.
    García-Vallejo JJ; van Kooyk Y
    Immunol Rev; 2009 Jul; 230(1):22-37. PubMed ID: 19594627
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.